Search research articles
Contact Us
Filters
Showing results (131-140 of 169) with videos related to
Page
of 17
Sort By:
Nature Communications
|
April 12, 2022
Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma
Jeppe Sejerø Holm, Samuel A Funt, Annie Borch, et al.
The Journal of Urology
|
February 1, 2023
Final Results of a Phase I Trial of WST-11 (TOOKAD Soluble) Vascular-targeted Photodynamic Therapy for Upper Tract Urothelial Carcinoma
Wesley Yip, Daniel D Sjoberg, Lucas M Nogueira, et al.
Cancer Discovery
|
June 18, 2014
Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy
Hikmat Al-Ahmadie, Gopa Iyer, Marcel Hohl, et al.
Science Translational Medicine
|
August 26, 2021
LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade
Ronglai Shen, Michael A Postow, Matthew Adamow, et al.
JAMA Oncology
|
November 1, 2019
Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer
Andrea B Apolo, Matthew I Milowsky, Lauren Kim, et al.
The Lancet. Oncology
|
May 13, 2024
Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial
Andrea Necchi, Mathieu Roumiguié, Ashish M Kamat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2023
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience
Brendan J Guercio, Michal Sarfaty, Min Yuen Teo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 25, 2018
Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma
François Audenet, Sumit Isharwal, Eugene K Cha, et al.
Cell Reports
|
December 21, 2022
Genomic heterogeneity as a barrier to precision oncology in urothelial cancer
Timothy N Clinton, Ziyu Chen, Hannah Wise, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2007
Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology
Julie Gralow, Robert F Ozols, Dean F Bajorin, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 169) with videos related to
Sort By:
Page
of 17
Nature Communications
|
April 12, 2022
Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma
Jeppe Sejerø Holm, Samuel A Funt, Annie Borch, et al.
The Journal of Urology
|
February 1, 2023
Final Results of a Phase I Trial of WST-11 (TOOKAD Soluble) Vascular-targeted Photodynamic Therapy for Upper Tract Urothelial Carcinoma
Wesley Yip, Daniel D Sjoberg, Lucas M Nogueira, et al.
Cancer Discovery
|
June 18, 2014
Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy
Hikmat Al-Ahmadie, Gopa Iyer, Marcel Hohl, et al.
Science Translational Medicine
|
August 26, 2021
LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade
Ronglai Shen, Michael A Postow, Matthew Adamow, et al.
JAMA Oncology
|
November 1, 2019
Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer
Andrea B Apolo, Matthew I Milowsky, Lauren Kim, et al.
The Lancet. Oncology
|
May 13, 2024
Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial
Andrea Necchi, Mathieu Roumiguié, Ashish M Kamat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2023
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience
Brendan J Guercio, Michal Sarfaty, Min Yuen Teo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 25, 2018
Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma
François Audenet, Sumit Isharwal, Eugene K Cha, et al.
Cell Reports
|
December 21, 2022
Genomic heterogeneity as a barrier to precision oncology in urothelial cancer
Timothy N Clinton, Ziyu Chen, Hannah Wise, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2007
Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology
Julie Gralow, Robert F Ozols, Dean F Bajorin, et al.
Page
of 17